204 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry

4737

Bionime
NT$68.30-1.0%-9.2%NT$4.2bNT$80.00PE670.4xn/a3.1%Healthcare

6634

Sinew Pharma
NT$57.500.9%-31.8%NT$4.1bn/aPB3.1xn/an/aPharmaceuticals & Biotech

4132

Golden Biotechnology
NT$28.70-2.0%-56.5%NT$4.1bn/aPS22xn/an/aPharmaceuticals & Biotech

8279

Syngen BiotechLtd
NT$150.00-2.0%-18.3%NT$4.1bNT$170.00PE14.8xE8.1%3.3%Pharmaceuticals & Biotech

8403

ShareHope Medicine
NT$32.052.4%-17.8%NT$4.0bn/aPE32.4xn/a1.5%Healthcare

4108

PhytoHealth
NT$20.000%-10.3%NT$4.0bn/aPS24.4xn/an/aPharmaceuticals & Biotech

6945

AP Biosciences
NT$60.804.3%n/aNT$3.9bn/aPS122.1xn/an/aPharmaceuticals & Biotech

6499

Medeon Biodesign
NT$42.450.1%-22.3%NT$3.9bn/aPS19.9xn/a1.1%Healthcare

4155

OK Biotech
NT$26.8012.6%-12.5%NT$3.9bn/aPE1325.2xn/a1.1%Healthcare

4138

Dynamic Medical Technologies
NT$116.50-0.4%49.4%NT$3.8bn/aPE18.3xn/a5.8%Healthcare

6461

Intech Biopharm
NT$27.401.7%-23.2%NT$3.8bn/aPS145.7xn/an/aPharmaceuticals & Biotech

1777

SYN-TECH Chem. & Pharm
NT$84.302.6%-13.0%NT$3.8bn/aPE15xn/a3.6%Pharmaceuticals & Biotech

6492

Senhwa Biosciences
NT$41.450.9%-18.7%NT$3.7bn/aPS3696.8xn/an/aPharmaceuticals & Biotech

4120

Orient EuroPharma
NT$42.000.8%12.6%NT$3.6bn/aPE25.3xn/a2.4%Pharmaceuticals & Biotech

6885

BRIM Biotechnology
NT$31.20-1.7%-59.7%NT$3.6bn/aPS40128.1xn/an/aPharmaceuticals & Biotech

1762

Chunghwa Chemical Synthesis & Biotech
NT$46.152.2%-51.8%NT$3.6bNT$48.00PE13.5xn/a1.7%Pharmaceuticals & Biotech

4747

Johnson Chemical Pharmaceutical Works
NT$77.005.9%27.5%NT$3.4bn/aPE43.2xn/a1.9%Pharmaceuticals & Biotech

1733

Apex Biotechnology
NT$33.650.1%21.0%NT$3.4bn/aPE29xn/a3.3%Healthcare

4169

TCM Biotech International
NT$55.90-3.8%6.3%NT$3.3bNT$113.00PE177.7xn/a0.5%Pharmaceuticals & Biotech

6926

Shine-On BioMedicalLtd
NT$65.000.3%-2.1%NT$3.2bn/aPS339.9xn/an/aPharmaceuticals & Biotech

7713

WeLeader Biomedical
NT$74.001.4%n/aNT$3.1bn/an/an/an/aHealthcare

1784

BIONET
NT$64.201.7%1.6%NT$3.0bn/aPE38.7xn/a1.1%Healthcare

4150

Unicon Optical
NT$20.6019.8%81.5%NT$3.0bn/aPS3.9xn/an/aHealthcare

6704

Gwo Xi Stem Cell Applied Technology
NT$31.100.3%-21.4%NT$3.0bn/aPS21.1xn/an/aPharmaceuticals & Biotech
Page 4 of 9
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.